Monoclonal Mouse anti‑Human RHOE / RND3 Antibody (clone 5C7E8, IHC, IF, WB) LS‑C669309
Monoclonal Mouse anti‑Human RHOE / RND3 Antibody (clone 5C7E8, IHC, IF, WB) LS‑C669309
Antibody:
RHOE / RND3 Mouse anti-Human Monoclonal (5C7E8) Antibody
Application:
IHC, IF, WB, Flo, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
RHOE / RND3 Mouse anti-Human Monoclonal (5C7E8) Antibody
Application:
IHC, IF, WB, Flo, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
RND3 antibody LS-C669309 is an unconjugated mouse monoclonal antibody to human RND3 (RHOE). Validated for ELISA, Flow, IF, IHC and WB.
Target
Human RHOE / RND3
Synonyms
RND3 | ARHE | Rho family GTPase 3 | RhoE | Small GTP binding protein Rho8 | MemB | Rho8 | Protein MemB
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of human RND3 (AA: 104-241) expressed in E. Coli.
Applications
- IHC
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:100 - 1:500)
- Flow Cytometry (1:200 - 1:400)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.05% Sodium Azide
Storage
Short term: store at 4°C. Long term: store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Mouse, Human
Applications:
ICC, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/19/2024